课题基金 / 基金详情

Understanding the mechanisms underlying the detrimental effects of NAFLD on the brain

Understanding the mechanisms underlying the detrimental effects of NAFLD on the brain
了解 NAFLD 对大脑产生有害影响的机制
批准号:
MR/X033287/1
负责人:
Anna Hadjihambi
金额:
$159.61万
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2024
资助国家:
英国
项目状态:
未结题
起止时间:
2024 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
许多研究表明,不健康的生活方式和肥胖对大脑的有害影响,以及与发展其他神经系统疾病(如痴呆症)风险增加的相关性。非酒精性脂肪性肝病(NAFLD)是一种严重的肝脏疾病,通常与其他慢性疾病共存,导致全球多发病(定义为同一人同时发生多种慢性疾病)的健康危机。NAFLD影响全世界大约五分之一的人,肥胖人群的患病率最高。现在越来越清楚的是,NAFLD正在影响包括大脑在内的其他器官,它与认知能力受损,抑郁情绪,焦虑,冷漠和大脑加速老化有关。大脑消耗了我们吸入的20%的氧气和我们消耗的20%的葡萄糖,氧气和代谢底物都通过血液输送到大脑。因此,血液供应不足会导致代谢缺陷,最终导致细胞损伤,导致认知能力下降和神经退行性疾病,如阿尔茨海默病和衰老。为了维持适当和充足的能量供应,大脑具有复杂的血管网络,通过输送氧气和营养物质以及确保代谢废物的清除来有效地维持大脑代谢稳态。我的研究表明,NAFLD与大脑血管密度降低有关,这导致氧气供应减少。仅这一点就可能导致认知和行为改变,以及NAFLD患者报告的痴呆风险增加。然而,我们对这些血管变化机制的了解有限,阻碍了对神经保护策略的研究。我的研究目的是促进我们对NAFLD相关异常生理过程的理解,重点是大脑和脑血管系统。我假设代谢供应减少是NAFLD患者认知功能障碍和生活质量下降的原因。我将研究NAFLD引起的大脑血管变化是否可以通过解决NAFLD来逆转,或者脑血管损伤是否是不可逆的,从而使大脑在衰老过程中更加脆弱。我将通过将先进的成像和分子技术应用于适当的NAFLD动物模型来实现这些目标。我将通过分析肥胖患者的人类生物医学数据来验证我的假设,有和没有NAFLD,以及减肥和逆转NAFLD的肥胖患者。这种方法的额外优势在于增加了我们对脂肪肝疾病对通常仅归因于肥胖的脑并发症的影响的理解。NAFLD是一种严重但未被充分认识的健康风险因素,也是一种重大的社会和经济负担,包括与健康相关的生活质量降低和医疗费用增加,预计未来10年英国和欧洲的医疗费用将达到2890亿英镑。这项研究获得的知识将对预防和治疗NAFLD的全球政策产生直接影响,并最终可能导致新型有效的神经保护策略的开发。
英文摘要
Numerous studies have shown the detrimental effects of an unhealthy lifestyle and obesity on the brain, as well as the association with increased risk for developing other neurological disorders, such as dementia. Non-alcoholic fatty liver disease (NAFLD) is a serious liver disorder, which often coexists with other chronic conditions, contributing to the global health crisis of multimorbidity (defined as multiple chronic diseases occurring in the same person at the same time). NAFLD affects approximately 1 in 5 people worldwide, with the highest prevalence in obese people. It is now becoming clear that NAFLD is affecting other organs including the brain and it is associated with impaired cognitive performance, depressive mood, anxiety, apathy and accelerated ageing of the brain. The brain consumes 20% of oxygen we inspire and 20% of glucose we consume, with both oxygen and metabolic substrates carried to the brain via the blood. Therefore, insufficient blood supply can result in metabolic deficit and eventually cellular damage, leading to cognitive decline and neurodegeneration, as seen in Alzheimer's disease and ageing. In order to maintain appropriate and sufficient energy supply, the brain has an intricate network of blood vessels, which effectively maintain brain metabolic homeostasis by delivering oxygen and nutrients, as well as by ensuring the clearance of metabolic waste products. My research indicated that NAFLD is associated with decreases in the density of blood vessels in the brain, which lead to a reduced oxygen supply. This alone could be responsible for the cognitive and behavioural alterations, as well as the increased risk of dementia reported in patients with NAFLD. However, the search for neuroprotective strategies is hampered by our limited understanding of the mechanisms underlying these vascular changes.The aim of my research is to advance our understanding of the abnormal physiological processes associated with NAFLD, focusing on the brain and cerebrovascular system. I hypothesise that reduced metabolic supply is responsible for the cognitive impairment and decreased quality of life reported in patients with NAFLD. I will investigate whether NAFLD induced changes in the brain's blood vessels can be reversed by resolving NAFLD, or if the cerebrovascular damage is irreversible, thus making the brain more fragile during ageing. I will address these aims by applying advanced imaging and molecular techniques to an appropriate animal model of NAFLD. I will test my hypothesis by analysing human biomedical data from obese patients, with and without NAFLD, and obese patients who lost weight and reversed NAFLD. This approach has the added advantage of increasing our understanding of the impact of a fatty liver disease on brain complications usually attributed to obesity only. NAFLD is a serious, yet underappreciated, health risk factor and a major substantial societal and economic burden, which includes reduced health-related quality of life and increased healthcare costs estimated to reach £289 billion in the UK and Europe in the next 10 years. The knowledge obtained by this research, will have direct impact on global policies towards the prevention and treatment of NAFLD and may ultimately lead to the development of novel and effective neuroprotective strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: